Message from the Chair: ISPE & Information Sharing
James A. Breen, Jr., PE
I hope 2019 is bringing exciting challenges and fulfillment to your personal and career goals.
Like 2018, 2019 will have its uncertainties and opportunities but our industry will continue to evolve to bring new life-saving therapies to patients around the world. This presents a tremendous opportunity for ISPE to provide leadership to highlight the technologies that will drive better outcomes for patients and prepare our membership for these evolving changes.
I recently had the opportunity to attend ISPE Biopharmaceutical Manufacturing Conference on 10–12 December 2018 in Huntington Beach, California. Manufacturing company owners, regulators, equipment vendors, and service providers shared information on how they are addressing the evolving needs of the industry in continuous, CAR-T, and oligonucleotides manufacturing.
Presenters focused on the speed of changing requirements in these new areas as, in some cases, the changes mean new standards are developing. Presenters also emphasized how we as an industry need to continue to work together to drive common platforms across our industry to allow us to bring these therapies to market quicker.
At the Biopharmaceutical Manufacturing Conference, we had a great turnout to our Women in Pharma® Roundtable Discussion—over 75 women and men attended and a panel shared their career and life experiences. (See more coverage of the WIP event and the Biopharmaceutical Manufacturing Conference.) The audience was very engaged during a breakout session that followed the presentations for all attendees to discuss how to address common workplace issues.
We at ISPE are committed to bringing relevant and timely information and training to our members to help them prepare for the new world of changing technology, business models, and workforce requirements.
I encourage you to get involved in ISPE at the chapter or affiliate level and help make our professional society the best it can be.
We look forward to seeing you at our upcoming conferences in 2019. The next ISPE Biopharmaceutical Manufacturing Conference 18–20 June in Boston, Massachusetts, will focus on cutting-edge technology that is shaping our industry and will demonstrate the skill sets you need to participate in this transformation.
The 2019 ISPE Europe Annual Conference 1–4 April in Dublin, Ireland will have as its theme Driving and Leveraging Innovation for Pharma. This promises to be an outstanding event in Ireland, which will have several new biologics facilities coming online over the next few years. Our Irish affiliate is working to make this event the largest Europe ISPE conference ever. (For more about the ISPE Ireland Affiliate, see their profile.)
As always, I encourage you to get involved in ISPE at the chapter or affiliate level and help make our professional society the best it can be. Only with member involvement and dedication can we drive our society and industry to the highest levels.
We welcomed 2023 with high hopes and dreams of what Women in Pharma® could eventually be. As I prepare to conclude my time as the Chair of ISPE’s International Women in Pharma Steering Committee, I do so with immense gratitude.
This is my last column in Pharmaceutical Engineering®. It has been my real pleasure and an honor to serve as your International Board Chair. Thank you for your support and I, like you, look forward to another phenomenal year for ISPE in 2024.